parexel

Private

—N/Ahttps://parexel.com

Last Round

Take Private

Nov 15, 2021

Last Round Size

$8.5B

Est. Valuation

$8.5B

Total Funding Raised

$13.52B

Company Overview

parexel has raised $13.52B. It was founded in 1982.

Provider of biopharmaceutical outsourcing services, including clinical trials management, regulatory consulting, and commercialization support for the life sciences industry.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

parexel Comparables

Compare parexel with similar companies based on industry and business-model similarity.

No comparables are published for parexel. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

parexel Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Take Private	Nov 15, 2021	Demo	Demo	Demo	Demo
Take Private	Oct 2, 2017	Demo	Demo	Demo	Demo
IPO	Nov 22, 1995	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

parexel Filings

Explore SEC and related filing metadata, where available.

parexel filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

Headquarters—

Year Founded1982

Last FundingNov 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?